Evaluation of CIN2+/CIN3+risk of Different HPV Subtypes Infection Combined with Abnormal Cytology Status
H X Luo,H Du,Z H Liu,L J Zhang,C Wang,R F Wu
DOI: https://doi.org/10.3760/cma.j.issn.0253-3766.2018.03.015
2018-01-01
Abstract:Objective To determine the morbidity of cervical intraepithelial neoplasia 2+(CIN2+) and CIN3+of different human papillomavirus(HPV)subtype infection combined with different cytology status.Methods The Shenzhen Cervical Cancer Screening Trial Ⅰ & Ⅱ(SHENCCASTⅠ&Ⅱ)are population-based cross-sectional cervical cancer screening studis conducted in Shenzhen and surrounding area from 2008 to2010.A total of 12 097 women who aged 25-59 years were included in the analysis.All of these women were detected by liquid-based cytology test and several high-risk HPV-DNA tests.The ones with HPV positive or atypical squamous cells of undetermined sign(ASC-US)were sequentially conducted by cervical biopsy vaginoscopy.Finally,10 805 samples with complete data of hybrid capture 2(HC2),the polymerase chain reaction-based matrix-assisted laser desorption/ionization time-of-flight assay(MALDI-TOF), HPV genotyping detection,cytology and pathology results were analyzed.Results The top 6 infection rates of HR-HPV in CIN2+and CIN3+were HPV16, HPV52, HPV58, HPV33, HPV31, HPV18.The highest constituent ratio of cytology in CIN 2+and CIN3+was high grade squamous intraepithelial lesion(HSIL).The morbidities of CIN2+of patients infected with HPV16, HPV31, HPV58, HPV33, HPV18, HPV52 were 41.3%, 31.5%, 30.6%, 28.7%, 28.2%, 17.7 %, respectively, while the morbidities of CIN3+of those were 33.5 %,20.5%, 19.4%, 15.7%, 19.2%,8.3%, respectively.The morbidities of CIN2+in negative intraepithelial lesion or malignancy(NILM),ASC-US, low grade squamous intraepithelial lesion(LSIL), atypical squamous cell cannot exclude high-grade squamous intraepithelial lesion(ASC-H), high grade squamous intraepithelial lesion(HSIL), atypical glandular cell(AGC)samples were 0.4%, 6.9%, 11.1%,36.4%,82.0%,16.7%,respectively,while the morbidities of CIN3+of those were 0.2%,3.1%, 4.2%,22.7%, 64.8%, 0.0%, respectively.The morbidities of CIN2+in NILM combined with HPV16, HPV18,HPV31, HPV33 infection were 12.6%, 13.3%, 15.8% and 11.5%, respectively, while the morbidities of CIN3+of those were 10.3%,11.1%,7.9%and 7.7%,respectively.The morbidities of CIN2+and CIN3+in ASC-US combining with hrHPV infection were high, and the top 6 subtypes associated with high risk of CIN2+were HPV31(35.7%), HPV33(26.9%), HPV16(26.5%), HPV58(22.4%), HPV52(18.6%), HPV68(15.4%), while those associated with high risk of CIN 3+were HPV16 (20.4%),HPV31(14.3%),HPV33(11.5%), HPV58(8.6%), HPV68(7.7%), HPV52(5.8%). Conclusions Cytology combined with HPV genotyping detection can more effectively estimate the morbidity risks of CIN2+and CIN3+.Both high prevalence rates and high risks associated with CIN 2+and CIN3+of HPV31,HPV33,HPV52 and HPV58 are observed.NILM and ASC-US status combined with these subtypes mentioned above are advised to be conducted by colposcopy.